The Food and Drug Administration (FDA) conducted an inspection of Wilmar Oleo North America, LLC in Pearland on Feb. 17, according to data published on the FDA’s website.
Inspectors assessed the following areas during the review:
- Foodborne Biological Hazards
- Monitoring of Marketed Animal Drugs, Feed, and Devices
The resulting report found no corrective action was required for any aspect of Wilmar Oleo North America, LLC’s management practices.
The FDA regularly inspects facilities nationwide to verify that workplaces and their products comply with FDA regulations aimed at advancing public health. These inspection outcomes are then shared with the public.
According to its website, the FDA is a federal agency tasked mainly with overseeing the safety and quality of human and animal drugs, biological products, medical supplies and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
